Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes
The aim of this study was to evaluate the impact of adipocyte fatty acid binding protein 4 (FABP4) on the lipid profile in type 2 diabetic subjects. Plasma levels of FABP4 and adiponectin and an extensive lipid profile were analyzed in 169 type 2 diabetic subjects and 105 controls. Type 2 diabetic s...
Main Authors: | Anna Cabré, Iolanda Lázaro, Josefa Girona, Josep Maria Manzanares, Francesc Marimón, Núria Plana, Mercedes Heras, Lluís Masana |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2008-08-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520346939 |
Similar Items
-
Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells
by: Aragonès Gemma, et al.
Published: (2012-06-01) -
FABP4 plasma levels are increased in familial combined hyperlipidemia
by: Anna Cabré, et al.
Published: (2010-05-01) -
Unveiling the Role of the Fatty Acid Binding Protein 4 in the Metabolic-Associated Fatty Liver Disease
by: Juan Moreno-Vedia, et al.
Published: (2022-01-01) -
Relationship Between Fatty Acid Binding Protein 4 and Liver Fat in Individuals at Increased Cardiometabolic Risk
by: Ricardo Rodríguez-Calvo, et al.
Published: (2021-12-01) -
Atherogenic dyslipidemia
by: C N Manjunath, et al.
Published: (2013-01-01)